Close

CSafe Global Expands Further into Asia Opening Hub Operations in Taipei, Taiwan

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Particulate Matter in Injectables: Risks and Controls

Based on available data from US FDA between Aug...

Receptor Grade IGF-1 LR3: Expansive Research Potential

Receptor Grade IGF-1 LR3, an engineered analog of Insulin-like...

API China 2025 kicks off with Industry Buzz on Day One

At the China Import and Export Fair Complex in...

FDA Plans to Deploy AI Tools for Scientific Reviews

The US Food and Drug Administration has announced plans...

CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, has once again expanded their global reach and local presence with the opening of a new hub operation in Taipei, Taiwan.

This new addition to CSafe’s worldwide container operations facilities ensures Taiwan’s thriving biotech and pharmaceutical sectors have consistent, easy access for to the cold chain industry’s top performing containers. “We’ve been supplying containers to Taipei for some time now from our Hong Kong facility,” explained Tom Weir, chief operating officer for CSafe Global. “As the demand has consistently increased over time, we felt it important to invest in a local hub where we can inspect and service incoming containers so they can be released for usage by local organizations. To do this efficiently, we’ve partnered with C.H. Robinson in Taipei to make units available at their Taiwan International Global Forwarding facility.” CSafe will have access to 2,500 square-feet of space to store CSafe RKN and RAP containers.

CSafe continues expanding its presence in Asia by investing in best-in-class facilities to provide the best service possible to customers in their local area.

Latest stories

Related stories

Particulate Matter in Injectables: Risks and Controls

Based on available data from US FDA between Aug...

Receptor Grade IGF-1 LR3: Expansive Research Potential

Receptor Grade IGF-1 LR3, an engineered analog of Insulin-like...

API China 2025 kicks off with Industry Buzz on Day One

At the China Import and Export Fair Complex in...

FDA Plans to Deploy AI Tools for Scientific Reviews

The US Food and Drug Administration has announced plans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back